Country’s pioneering scientific project GenomeIndia will yield the long-term benefit of reducing disease burden, thereby creating a healthier population in the country, said a renowned scientist on ...

The partner of Theranos founder Elizabeth Holmes has raised millions of dollars for an artificial intelligence startup hoping to introduce a product that can be used in medical testing and other ...

Holmes' support for her partner's foray into biotech is striking, given she is serving a federal prison sentence for fraud in that same field. Over the course of her nearly four-month criminal trial, ...

The Business of Pride Business of Pride Annual Celebration and Awards Ceremony! Another big biotech pledges billions for U.S. manufacturing Another big biotech pledges billions for U.S ...

Xoted Biotechnology Labs, a subsidiary of DRC Ventures, will establish its new research and development center at The Spark Center at Spartanburg Community College's Tyger River Campus in Duncan.

The California biotech said it’s now planning an additional $11 billion in capital and operational investments in the U.S. on top of $21 billion already committed for U.S. manufacturing, research and ...

The longevity startup is part of a broader trend of billionaire-backed longevity ventures. NewLimit, a biotechnology startup co-founded by Coinbase CEO Brian Armstrong, has raised $130 million in a ...

Central Ohio's biotech sector has exploded in just five years, with four companies now employing 1,200 people in high-paying jobs. After $600M acquisition, biotech founder finds her new venture ...

The analysts noted, however, that “Makary does not seem to want to disrupt oncology and rare disease approvals.” The S&P Biotech ETF fell by more than 5% upon news of Prasad’s appointment, STAT News ...

First, let’s take a look at the private biotech investments in April 2025, breaking them down by value, location, funding type, and therapeutic subsector. April 2025 saw Biohaven announce that it had ...

According to Andrew Goodman, a partner in the M&A practice at business law firm Paul Hastings, reductions in staff at the FDA are putting pressure on biotech companies, especially those strapped ...